The efficacy of lopinavir in individuals experiencing protease inhibitor failure

被引：7

作者：

Gilleece, YC ^{[1
]}

Qazi, NA ^{[1
]}

Morlese, JF ^{[1
]}

Mandalia, S ^{[1
]}

Gazzard, BG ^{[1
]}

Pozniak, AL ^{[1
]}

Nelson, MR ^{[1
]}

机构：

[1] Chelsea & Westminster Hosp, St Stephens Ctr, London, England

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2003年 / 32卷 / 02期

关键词：

D O I：

10.1097/00126334-200302010-00018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：238 / 240

页数：3

共 15 条

[1]

Baxter J, 1999, ANTIVIR THER S, V4, P43

[2]

Behrens G, 1998, LANCET, V351, P1958, DOI 10.1016/S0140-6736(98)26026-0

[3]

FEINBERG J, 2001, AIDS S, V14, pS46

[4] Severe premature coronary artery disease with protease inhibitors [J].

Henry, K ;

Melroe, H ;

Huebsch, J ;

Hermundson, J ;

Levine, C ;

Swensen, L ;

Daley, J .

LANCET, 1998, 351 (9112) :1328-1328

[5]

Hsu A, 2000, AIDS, V14, pS12

[6]

HSU A, 2000, 40 INT C ANT AG CHEM

[7] QUANTITATIVE DETECTION OF HIV-1 DRUG-RESISTANCE MUTATIONS BY AUTOMATED DNA-SEQUENCING [J].

LARDER, BA ;

KOHLI, A ;

KELLAM, P ;

KEMP, SD ;

KRONICK, M ;

HENFREY, RD .

NATURE, 1993, 365 (6447) :671-673

[8]

LOUTFY M, 2002, 9 C RETR OPP INF FEB

[9]

Miller V, 2000, ANTIVIR THER, V5, P49

[10]

Podzamczer D, 2000, AIDS, V14, pS8

← 1 2 →